Want to see HK:6609 full AI Analyst Report?
Shanghai Heartcare Medical Technology Corp. Ltd. Class H (6609) Ratios
Shanghai Heartcare Medical Technology Corp. Ltd. Class H Ratios
HK:6609's free cash flow for Q2 2026 was $672.50K. For the 2026 fiscal year, HK:6609's free cash flow was decreased by $-4.33M and operating cash flow was $5.01M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 11.49 | 12.42 | 16.82 | 16.77 | 24.05 |
| Quick Ratio | 9.74 | 10.34 | 14.37 | 14.81 | 23.47 |
| Cash Ratio | 6.23 | 7.30 | 10.41 | 12.89 | 21.99 |
| Solvency Ratio | 0.84 | 0.13 | -0.49 | -1.15 | -1.38 |
| Operating Cash Flow Ratio | 1.63 | -0.04 | -1.48 | -3.95 | -3.72 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -53.35 | 0.00 |
| Net Current Asset Value | $ 954.13M | $ 879.80M | $ 879.79M | $ 984.94M | $ 1.20B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 |
| Debt-to-Equity Ratio | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 |
| Debt-to-Capital Ratio | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.14 | 1.14 | 1.12 | 1.13 | 1.10 |
| Debt Service Coverage Ratio | 33.70 | 11.57 | -27.62 | -23.28 | -77.55 |
| Interest Coverage Ratio | 21.48 | -3.57 | -58.35 | -92.40 | -66.14 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.18 | 0.99 | 1.01 | 1.38 | 1.33 |
| Net Debt to EBITDA | -7.54 | -25.89 | 8.55 | 4.90 | 6.41 |
| Profitability Margins | |||||
| Gross Profit Margin | 66.66% | 65.39% | 65.33% | 67.93% | 61.00% |
| EBIT Margin | 10.84% | -3.69% | -43.37% | -108.78% | -217.05% |
| EBITDA Margin | 17.77% | 7.87% | -29.48% | -91.41% | -203.51% |
| Operating Profit Margin | 10.85% | -2.24% | -54.20% | -108.49% | -173.57% |
| Pretax Profit Margin | 21.16% | -4.32% | -44.30% | -109.95% | -219.68% |
| Net Profit Margin | 20.41% | -4.90% | -40.46% | -109.48% | -215.59% |
| Continuous Operations Profit Margin | 20.41% | -4.90% | -40.46% | -109.48% | -219.68% |
| Net Income Per EBT | 96.44% | 113.59% | 91.34% | 99.57% | 98.14% |
| EBT Per EBIT | 195.12% | 192.30% | 81.74% | 101.35% | 126.57% |
| Return on Assets (ROA) | 6.45% | -1.13% | -7.83% | -15.27% | -12.91% |
| Return on Equity (ROE) | 7.36% | -1.28% | -8.74% | -17.19% | -14.15% |
| Return on Capital Employed (ROCE) | 3.70% | -0.55% | -11.03% | -15.95% | -10.79% |
| Return on Invested Capital (ROIC) | 3.54% | -0.55% | -10.03% | -15.74% | -10.77% |
| Return on Tangible Assets | 6.65% | -1.17% | -8.15% | -15.86% | -13.37% |
| Earnings Yield | 4.56% | -1.75% | -9.16% | -16.14% | -6.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.27 | 2.85 | 2.70 | 6.66 | 4.76 |
| Payables Turnover | 5.77 | 5.69 | 21.97 | 14.21 | 9.23 |
| Inventory Turnover | 0.82 | 0.56 | 0.55 | 0.44 | 1.09 |
| Fixed Asset Turnover | 5.23 | 2.36 | 1.68 | 1.46 | 0.78 |
| Asset Turnover | 0.32 | 0.23 | 0.19 | 0.14 | 0.06 |
| Working Capital Turnover Ratio | 0.42 | 0.29 | 0.23 | 0.16 | 0.09 |
| Cash Conversion Cycle | 467.86 | 713.37 | 780.30 | 850.91 | 370.86 |
| Days of Sales Outstanding | 85.49 | 128.22 | 135.16 | 54.82 | 76.70 |
| Days of Inventory Outstanding | 445.58 | 649.35 | 661.75 | 821.78 | 333.72 |
| Days of Payables Outstanding | 63.21 | 64.19 | 16.62 | 25.69 | 39.57 |
| Operating Cycle | 531.07 | 777.57 | 796.92 | 876.60 | 410.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.07 | -0.09 | -2.32 | -6.97 | -6.16 |
| Free Cash Flow Per Share | 3.70 | -0.22 | -3.62 | -7.94 | -7.80 |
| Dividend Paid and CapEx Coverage Ratio | 10.88 | -0.63 | -1.79 | -7.16 | -3.78 |
| Capital Expenditure Coverage Ratio | 10.88 | -0.63 | -1.79 | -7.16 | -3.78 |
| Operating Cash Flow Coverage Ratio | 3.61 | -0.09 | -2.43 | -5.26 | -4.91 |
| Operating Cash Flow to Sales Ratio | 0.38 | -0.01 | -0.38 | -1.46 | -2.28 |
| Free Cash Flow Yield | 7.66% | -1.08% | -13.42% | -24.48% | -9.16% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 21.83 | -57.16 | -10.92 | -6.20 | -14.63 |
| Price-to-Sales (P/S) Ratio | 4.47 | 2.80 | 4.42 | 6.79 | 31.55 |
| Price-to-Book (P/B) Ratio | 1.61 | 0.73 | 0.95 | 1.07 | 2.07 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.05 | -92.80 | -7.45 | -4.09 | -10.92 |
| Price-to-Operating Cash Flow Ratio | 11.85 | -240.76 | -11.61 | -4.66 | -13.81 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | 0.67 | 0.21 | 0.62 | -2.52 |
| Enterprise Value Multiple | 17.64 | 9.72 | -6.43 | -2.53 | -9.09 |
| Enterprise Value | 1.28B | 212.46M | 440.60M | 422.48M | 1.67B |
| EV to EBITDA | 17.64 | 9.72 | -6.43 | -2.53 | -9.09 |
| EV to Sales | 3.13 | 0.76 | 1.90 | 2.31 | 18.50 |
| EV to Free Cash Flow | 9.14 | -25.32 | -3.20 | -1.39 | -6.40 |
| EV to Operating Cash Flow | 8.30 | -65.69 | -4.98 | -1.58 | -8.09 |
| Tangible Book Value Per Share | 29.54 | 26.98 | 27.00 | 29.17 | 39.54 |
| Shareholders’ Equity Per Share | 29.91 | 28.13 | 28.25 | 30.45 | 41.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.04 | -0.14 | 0.09 | 0.00 | 0.00 |
| Revenue Per Share | 10.78 | 7.36 | 6.10 | 4.78 | 2.70 |
| Net Income Per Share | 2.20 | -0.36 | -2.47 | -5.24 | -5.82 |
| Tax Burden | 0.96 | 1.14 | 0.91 | 1.00 | 0.98 |
| Interest Burden | 1.95 | 1.17 | 1.02 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.10 | 0.21 | 0.53 | 0.84 | 0.85 |
| SG&A to Revenue | 0.46 | 0.50 | 0.32 | 0.39 | 1.29 |
| Stock-Based Compensation to Revenue | 0.05 | 0.00 | 0.05 | 0.08 | 0.57 |
| Income Quality | 1.78 | 0.27 | 0.94 | 1.33 | 1.04 |
Currency in CNY
